GovindanGopinathanMD

PubMed

• 2 citations
  Recognition and treatment of migraine patient in dental practice.
  Mea A. Weinberg, Govindan Gopinathan> ;The New York State Dental Journal. 2009 Mar 1
• 22 citations
  Randomized double-blind cross-over study of Sinemet-controlled release (CR4 50/200) versus Sinemet 25/100 in Parkinson's disease.
  Abraham Lieberman, Govindan Gopinathan, Edith Miller, Andreas Neophytides, Greg Baumann, Linda Chin> ;European Neurology. 1990 Jan 1
• Mesulergine: a dopamine agonist with novel properties in Parkinson's disease.
  Abraham Lieberman, Govindan Gopinathan, P. Pasternack, Menek Goldstein> ;Advances in Neurology. 1990 Jan 1
• 91 citations
  Deprenyl in the Treatment of Symptom Fluctuations in Advanced Parkinson's Disease
  Lawrence I. Golbe, Abraham Lieberman, Manfred D. Muenter, J. E. Ahlskog, Govindan Gopinathan, Andreas Neophytides, Sun-Hoo Foo, Roger C. Duvoisin> ;Clinical Neuropharmacology. 1988 Feb 1
• 24 citations
  Deprenyl versus placebo in Parkinson disease: a double-blind study.
  Lieberman An, Govindan Gopinathan, Andreas Neophytides, Son Hoo Foo> ;New York State Journal of Medicine. 1987 Dec 1
• 18 citations
  D-1 and D-2 agonists in Parkinson's disease.
  Abraham Lieberman, Menek Goldstein, Govindan Gopinathan, Andreas Neophytides> ;The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1987 Aug 1
• 5 citations
  Advanced Parkinson's disease Use of partial dopamine agonist, ciladopa
  Lieberman An, Govindan Gopinathan, Andreas Neophytides, P. Pasternack, Menek Goldstein> ;Neurology. 1987 May 1
• Use of carbidopa as an adjuvant to levodopa/carbidopa therapy in patients with Parkinson's disease.
  Lieberman An, Govindan Gopinathan, Andreas Neophytides, P. Pasternack> ;New York State Journal of Medicine. 1986 Dec 1
• 6 citations
  Efficacy of pergolide and mesulergine.
  Abraham Lieberman, Govindan Gopinathan, Andreas Neophytides> ;European Neurology. 1986 Jan 1
• 5 citations
  Management of levodopa failures: the use of dopamine agonists.
  Abraham Lieberman, Govindan Gopinathan, Andreas Neophytides, Menek Goldstein> ;Clinical Neuropharmacology. 1986 Jan 1
• 10 citations
  Review: The Use of Pergolide and Lisuride, Two Experimental Dopamine Agonists, in Patients with Advanced Parkinson Disease
  Abraham Lieberman, Morton Leibowitz, Govindan Gopinathan, Russell W. Walker, Emile M. Hiesiger, Jeffrey Nelson, Menek Goldstein> ;The American Journal of the Medical Sciences. 1985 Sep 1
• 8 citations
  Should dopamine agonists be given early or late? A review of nine years experience with bromocriptine.
  Abraham Lieberman, Govindan Gopinathan, Hassan Hassouri, Andreas Neophytides, Menek Goldstein> ;The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1984 Feb 1
• 8 citations
  Combined use of benserazide and carbidopa in Parkinson's disease
  Menek Goldstein, Govindan Gopinathan, Andreas Neophytides, Emile M. Hiesiger, Russell W. Walker, Jeffrey A. Nelson> ;Neurology. 1984 Feb 1
• 14 citations
  Long‐term treatment with pergolide: Decreased efficacy with time
  Morton Leibowitz, Abraham Lieberman, Govindan Gopinathan, Menek Goldstein, Andreas Neophytides, Emile M. Hiesiger, Jeffrey A. Nelson, Russell W. Walker> ;Neurology. 1984 Feb 1
• 9 citations
  Pergolide and lisuride in advanced Parkinson's disease.
  Lieberman An, Govindan Gopinathan, Andreas Neophytides, Morton Leibowitz, Menek Goldstein> ;Advances in Neurology. 1984 Jan 1
• 9 citations
  Deprenyl in the treatment of Parkinson's disease. A specific type B monoamine oxidase inhibitor.
  Lieberman An, Govindan Gopinathan, Andreas Neophytides, Emile M. Hiesiger, Jeffrey A. Nelson, Russell W. Walker, Albert Goodgold> ;New York State Journal of Medicine. 1984 Jan 1
• 39 citations
  Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
  Lieberman An, Andreas Neophytides, Morton Leibowitz, Govindan Gopinathan, Russell W. Walker, Albert Goodgold, Menek Goldstein> ;Advances in Neurology. 1983 Jan 1
• 10 citations
  The effects of pergolide on the cardiovascular system of 40 patients with Parkinson's disease.
  Morton Leibowitz, Lieberman An, Andreas Neophytides, Govindan Gopinathan, Menek Goldstein> ;Advances in Neurology. 1983 Jan 1
• 18 citations
  Bromocriptine and lisuride in Parkinson disease.
  Abraham Lieberman, Govindan Gopinathan, Andreas Neophytides, Morton Leibowitz, Russell W. Walker, Emil Hiesiger> ;Annals of Neurology. 1983 Jan 1
• 3 citations
  Further Studies with Lisuride in Parkinson’s Disease
  Abraham Lieberman, Menek Goldstein, Govindan Gopinathan, Morton Leibowitz, Andreas Neophytides, Russell W. Walker, Emil Hiesiger> ;European Neurology. 1983 Jan 1
• 10 citations
  Treatment of "on-off" phenomena with lithium.
  Abraham Lieberman, Govindan Gopinathan> ;Annals of Neurology. 1982 Oct 1
• 27 citations
  Further studies with pergolide in Parkinson disease
  Abraham Lieberman, Menek Goldstein, Govindan Gopinathan, Morton Leibowitz, Andreas Neophytides, Russell W. Walker, Emil Hiesiger, Jeffrey A. Nelson> ;Neurology. 1982 Oct 1
• 7 citations
  The use of pergolide, a potent dopamine agonist, in Parkinson's disease.
  Abraham Lieberman, Menek Goldstein, Andreas Neophytides, Morton Leibowitz, Govindan Gopinathan, Russell W. Walker, Virginia Pact> ;Clinical Pharmacology and Therapeutics. 1982 Jul 1
• 24 citations
  The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy.
  Andreas Neophytides, Lieberman An, Menek Goldstein, Govindan Gopinathan, Morton Leibowitz, J Bock, Russell W. Walker> ;Journal of Neurology, Neurosurgery, and Psychiatry. 1982 Mar 1
• 19 citations
  Cardiac effects of pergolide
  Morton Leibowitz, Abraham Lieberman, Menek Goldstein, Andreas Neophytides, Mark J. Kupersmith, Govindan Gopinathan, Sidney Mehl> ;Clinical Pharmacology and Therapeutics. 1981 Dec 1
• Join now to see all